These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8996829)

  • 1. Brain and erythrocyte anion transporter protein, band 3, as a marker for Alzheimer's disease: structural changes detected by electron microscopy, phosphorylation, and antibodies.
    Kay MM; Goodman J
    Gerontology; 1997; 43(1-2):44-66. PubMed ID: 8996829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posttranslational modifications of brain and erythrocyte band 3 during aging and disease.
    Kay MM; Rapcsak SZ; Bosman GJ; Goodman JR
    Cell Mol Biol (Noisy-le-grand); 1996 Nov; 42(7):919-44. PubMed ID: 8960771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies to band 3 during aging and disease and aging interventions.
    Kay MM; Wyant T; Goodman J
    Ann N Y Acad Sci; 1994 May; 719():419-47. PubMed ID: 7516632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of senescent cell antigen on old cells initiates IgG binding to a neoantigen.
    Kay MM
    Cell Mol Biol (Noisy-le-grand); 1993 Mar; 39(2):131-53. PubMed ID: 8513271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Band 3 and its peptides during aging, radiation exposure, and Alzheimer's disease: alterations and self-recognition.
    Kay MM; Lake D; Cover C
    Adv Exp Med Biol; 1995; 383():167-93. PubMed ID: 8644501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttranslational changes in band 3 in adult and aging brain following treatment with ergoloid mesylates, comparison to changes observed in Alzheimer's disease.
    Cover CC; Poulin JE; Gustafson MR; Wyant T; Gamble DN; Kay MM
    Life Sci; 1996; 58(8):655-64. PubMed ID: 8594315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping of senescent cell antigen on brain anion exchanger protein (AE) isoforms using HPLC and fast atom bombardment ionization mass spectrometry (FAB-MS).
    Kay MM; Goodman J
    J Mol Recognit; 2004; 17(1):33-40. PubMed ID: 14872535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Band 3 in aging and neurological disease.
    Kay MM
    Ann N Y Acad Sci; 1991; 621():179-204. PubMed ID: 1859086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Definition of a physiologic aging autoantigen by using synthetic peptides of membrane protein band 3: localization of the active antigenic sites.
    Kay MM; Marchalonis JJ; Hughes J; Watanabe K; Schluter SF
    Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5734-8. PubMed ID: 1696010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly-N-acetyllactosaminyl saccharide chains of band 3 as determinants for anti-band 3 autoantibody binding to senescent and oxidized erythrocytes.
    Beppu M; Ando K; Kikugawa K
    Cell Mol Biol (Noisy-le-grand); 1996 Nov; 42(7):1007-24. PubMed ID: 8960777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteins immunologically related to erythrocyte anion transporter band 3 are altered in brain areas affected by Alzheimer's disease.
    Bosman GJ; Van Workum FP; Renkawek K; Van Kalmthout PJ; Bartholomeus IG; De Grip WJ
    Acta Neuropathol; 1993; 86(4):353-9. PubMed ID: 8256585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution and function of multiple anion transporter proteins in brain tumor cell lines in relation to glucose transport.
    Goodman JR; Gamble D; Kay MM
    Brain Res Bull; 1994; 33(4):411-7. PubMed ID: 8124579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG red blood cell autoantibodies in autoimmune hemolytic anemia bind to epitopes on red blood cell membrane band 3 glycoprotein.
    Victoria EJ; Pierce SW; Branks MJ; Masouredis SP
    J Lab Clin Med; 1990 Jan; 115(1):74-88. PubMed ID: 1688911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation of the human erythrocyte membrane band 3 studied with monoclonal antibody directed against an epitope on the cytoplasmic fragment of band 3.
    Czerwiński M; Waśniowska K; Steuden I; Duk M; Wiedłocha A; Lisowska E
    Eur J Biochem; 1988 Jul; 174(4):647-54. PubMed ID: 2455637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of band 3 transport protein by cellular aging and disease: erythrocyte band 3 and glucose transporter share a functional relationship.
    Bosman GJ; Kay MM
    Biochem Cell Biol; 1990 Dec; 68(12):1419-27. PubMed ID: 2085437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane protein band 3 alteration associated with neurologic disease and tissue-reactive antibodies.
    Kay MM; Goodman J; Goodman S; Lawrence C
    Exp Clin Immunogenet; 1990; 7(3):181-99. PubMed ID: 2383405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmented erythrocyte band-3 phosphorylation in septic mice.
    Condon MR; Feketova E; Machiedo GW; Deitch EA; Spolarics Z
    Biochim Biophys Acta; 2007 May; 1772(5):580-6. PubMed ID: 17382523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drosophila to bacteriophage to erythrocyte: the erythrocyte as a model for molecular and membrane aging of terminally differentiated cells.
    Kay MM
    Gerontology; 1991; 37(1-3):5-32. PubMed ID: 2055499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The membrane domain of the human erythrocyte anion transport protein. Epitope mapping of a monoclonal antibody defines the location of a cytoplasmic loop near the C-terminus of the protein.
    Wainwright SD; Mawby WJ; Tanner MJ
    Biochem J; 1990 Nov; 272(1):265-8. PubMed ID: 1702290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoregulation of cellular life span.
    Kay M
    Ann N Y Acad Sci; 2005 Dec; 1057():85-111. PubMed ID: 16399889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.